Global Retirement Partners’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51.3K | Buy |
+2,022
| New | +$47.8K | ﹤0.01% | 2505 |
|
|
2025
Q4 | $52.5K | Buy |
2,028
+1,678
| +479% | +$39.9K | ﹤0.01% | 2317 |
|
|
2025
Q3 | $9.02K | Hold |
350
| – | – | ﹤0.01% | 2744 |
|
|
2025
Q2 | $8.37K | Buy |
+350
| New | +$8.82K | ﹤0.01% | 2690 |
|
|
2024
Q4 | $6.59K | Hold |
350
| – | – | ﹤0.01% | 2562 |
|
|
2024
Q3 | $5.27K | Sell |
350
-52
| -13% | -$889 | ﹤0.01% | 2537 |
|
|
2024
Q2 | $11.5K | Buy |
402
+52
| +15% | +$1.48K | ﹤0.01% | 2254 |
|
|
2024
Q1 | $10.2K | Hold |
350
| – | – | ﹤0.01% | 2117 |
|
|
2023
Q4 | $11.3K | Hold |
350
| – | – | ﹤0.01% | 2025 |
|
|
2023
Q3 | $10K | Hold |
350
| – | – | ﹤0.01% | 1955 |
|
|
2023
Q2 | $14K | Sell |
350
-15
| -4% | -$620 | ﹤0.01% | 1833 |
|
|
2023
Q1 | $15.7K | Buy |
365
+15
| +4% | +$597 | ﹤0.01% | 1742 |
|
|
2022
Q4 | $13.5K | Sell |
350
-17
| -5% | -$827 | ﹤0.01% | 1648 |
|
|
2022
Q3 | $19K | Buy |
367
+4
| +1% | +$222 | ﹤0.01% | 1420 |
|
|
2022
Q2 | $21K | Buy |
363
+13
| +4% | +$852 | ﹤0.01% | 1344 |
|
|
2022
Q1 | $21K | Buy |
+350
| New | +$23.3K | ﹤0.01% | 1331 |
|
|
2021
Q4 | – | Sell |
-350
| Closed | -$20K | – | 1324 |
|
|
2021
Q3 | $20K | Hold |
350
| – | – | ﹤0.01% | 1205 |
|
|
2021
Q2 | $21K | Hold |
350
| – | – | ﹤0.01% | 1177 |
|
|
2021
Q1 | $25K | Hold |
350
| – | – | ﹤0.01% | 1036 |
|
|
2020
Q4 | $21K | Hold |
350
| – | – | ﹤0.01% | 1016 |
|
|
2020
Q3 | $21K | Hold |
350
| – | – | ﹤0.01% | 908 |
|
|
2020
Q2 | $18K | Hold |
350
| – | – | ﹤0.01% | 935 |
|
|
2020
Q1 | $12K | Hold |
350
| – | – | ﹤0.01% | 982 |
|
|
2019
Q4 | $16K | Hold |
350
| – | – | ﹤0.01% | 1022 |
|
|
2019
Q3 | $13K | Hold |
350
| – | – | ﹤0.01% | 1055 |
|
|
2019
Q2 | $15K | Hold |
350
| – | – | ﹤0.01% | 1011 |
|
|
2019
Q1 | $13K | Hold |
350
| – | – | ﹤0.01% | 983 |
|
|
2018
Q4 | $15K | Hold |
350
| – | – | ﹤0.01% | 851 |
|
|
2018
Q3 | $17K | Hold |
350
| – | – | ﹤0.01% | 875 |
|
|
2018
Q2 | $11K | Hold |
350
| – | – | ﹤0.01% | 979 |
|
|
2018
Q1 | $11K | Hold |
350
| – | – | ﹤0.01% | 942 |
|
|
2017
Q4 | $16K | Hold |
350
| – | – | ﹤0.01% | 783 |
|
|
2017
Q3 | $13K | Hold |
350
| – | – | 0.01% | 745 |
|
|
2017
Q2 | $17K | Hold |
350
| – | – | 0.01% | 648 |
|
|
2017
Q1 | $16K | Hold |
350
| – | – | 0.01% | 612 |
|
|
2016
Q4 | $11K | Buy |
+350
| New | +$11.7K | 0.01% | 668 |
|
Other funds holding PCRX
DPCM
Global Retirement Partners's PCRX Position: Q2 2026 in Review
Global Retirement Partners opened a new position in Pacira BioSciences (PCRX) in Q2 2026: 2,022 shares worth $51.3K. The stake represents ﹤0.01% of the portfolio and ranks #2505 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in PCRX as recently as Q4 2025.
Global Retirement Partners first reported a position in PCRX in Q4 2016 and has held it in 36 quarters since. The position peaked at $52.5K in Q4 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.
- Global Retirement Partners held 2,022 shares of Pacira BioSciences worth $51.3K as of Q2 2026.
- Pacira BioSciences was a new Global Retirement Partners position in Q2 2026.
- Pacira BioSciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2505 holding.
- Global Retirement Partners first reported a position in Pacira BioSciences in Q4 2016 and has held it in 36 quarters since.
- Global Retirement Partners's Pacira BioSciences position peaked at $52.5K in Q4 2025.
- 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.